Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Withdrawn Phase Trials for Melphalan (DB01042)

IndicationStatusPhase
DBCOND0029297 (Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01795430Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing SarcomaTreatment